Caladrius Biosciences (CLBS) Reports Q4 Loss Per Share of 59c, Affirms FY16 Rev. Guidance

Go back to Caladrius Biosciences (CLBS) Reports Q4 Loss Per Share of 59c, Affirms FY16 Rev. Guidance
Commerical Bank Shares Inc (NASDAQ: CLBS) Delayed: 0.43 --0 (-0%)
Previous Close $0.43    52 Week High $6.31 
Open $127.32    52 Week Low $0.41 
Day High $0.43    P/E N/A 
Day Low $0.43    EPS $0.00 
Volume 471,095